Cerus Corporation (CERS)
Largest Insider Buys in Sector
CERS Stock Price History Chart
CERS Stock Performance
About Cerus Corporation
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.
Insider Activity of Cerus Corporation
Over the last 12 months, insiders at Cerus Corporation have bought $67,242 and sold $1.03M worth of Cerus Corporation stock.
On average, over the past 5 years, insiders at Cerus Corporation have bought $215,060 and sold $3.59M worth of stock each year.
Highest buying activity among insiders over the last 12 months: BJERKHOLT ERIC (director) — $48,600. Witney Frank (director) — $37,800. Swisher Daniel N JR (director) — $14,066.
The last purchase of 2,500 shares for transaction amount of $4,975 was made by Shan Hua (director) on 2024‑05‑13.
List of Insider Buy and Sell Transactions, Cerus Corporation
| 2024-09-04 | Sale | Chief Financial Officer | 54,272 0.0299% | $2.15 | $116,826 | -15.64% | ||
| 2024-09-03 | Sale | Chief Financial Officer | 28,385 0.0153% | $2.18 | $61,919 | -18.49% | ||
| 2024-08-15 | Sale | Chief Legal Officer | 16,667 0.0092% | $2.06 | $34,417 | 0.00% | ||
| 2024-08-02 | Sale | Chief Medical Officer | 21,605 0.0125% | $2.50 | $54,013 | -22.13% | ||
| 2024-05-13 | director | 2,500 0.0013% | $1.99 | $4,975 | -8.00% | |||
| 2024-05-10 | director | 2,000 0.0011% | $1.79 | $3,578 | +6.65% | |||
| 2024-05-09 | director | 20,000 0.0107% | $1.89 | $37,800 | -4.17% | |||
| 2024-05-09 | director | 2,500 0.0013% | $1.88 | $4,689 | -4.17% | |||
| 2024-03-14 | Sale | President and CEO | 63,611 0.0349% | $2.02 | $128,195 | -8.54% | ||
| 2024-03-14 | Sale | Chief Scientific Officer | 14,360 0.0077% | $1.97 | $28,352 | -8.54% | ||
| 2024-03-14 | Sale | Chief Operating Officer | 26,794 0.0144% | $1.97 | $52,902 | -8.54% | ||
| 2024-03-14 | Sale | Chief Financial Officer | 21,497 0.0116% | $1.97 | $42,444 | -8.54% | ||
| 2024-03-14 | Sale | Chief Legal Officer | 17,824 0.0096% | $1.97 | $35,192 | -8.54% | ||
| 2024-03-14 | Sale | Chief Medical Officer | 17,738 0.0095% | $1.97 | $35,022 | -8.54% | ||
| 2024-03-13 | Sale | President and CEO | 62,315 0.0349% | $2.06 | $128,182 | -9.90% | ||
| 2024-03-13 | Sale | Chief Scientific Officer | 14,067 0.0079% | $2.06 | $28,936 | -9.90% | ||
| 2024-03-13 | Sale | Chief Operating Officer | 26,247 0.0147% | $2.06 | $53,990 | -9.90% | ||
| 2024-03-13 | Sale | Chief Financial Officer | 21,058 0.0116% | $2.02 | $42,438 | -9.90% | ||
| 2024-03-13 | Sale | Chief Legal Officer | 17,460 0.0098% | $2.06 | $35,915 | -9.90% | ||
| 2024-03-13 | Sale | SVP Reg. & Quality | 20,619 0.0113% | $2.02 | $41,553 | -9.90% |
Insider Historical Profitability
| Greenman William Mariner | President and CEO | 3181281 1.713% | $1.76 | 5 | 12 | +31.07% |
| CORASH LAURENCE M | Chief Scientific Officer | 2339740 1.2599% | $1.76 | 37 | 8 | +15.14% |
| Jayaraman Vivek K | Chief Operating Officer | 878653 0.4731% | $1.76 | 0 | 9 | |
| Green Kevin Dennis | Chief Financial Officer | 536093 0.2887% | $1.76 | 0 | 30 | |
| Moore Carol | SVP Reg. & Quality | 490623 0.2642% | $1.76 | 0 | 19 | |
| Jensen Chrystal | Chief Legal Officer | 474245 0.2554% | $1.76 | 0 | 20 | |
| Benjamin Richard J | Chief Medical Officer | 438007 0.2358% | $1.76 | 0 | 21 | |
| Witney Frank | director | 180059 0.097% | $1.76 | 2 | 0 | +47.63% |
| BJERKHOLT ERIC | director | 142133 0.0765% | $1.76 | 4 | 0 | +22.01% |
| NACHTSHEIM JAMI K | director | 108362 0.0583% | $1.76 | 2 | 0 | +47.63% |
| Swisher Daniel N JR | director | 107045 0.0576% | $1.76 | 3 | 5 | +22.26% |
| Shan Hua | director | 32386 0.0174% | $1.76 | 1 | 0 | |
| BAXTER INTERNATIONAL INC & SUBSIDIARIES PENSION TRUST | 10 percent owner | 2192700 1.1807% | $1.76 | 0 | 9 | |
| CASSIN BJ | director | 487921 0.2627% | $1.76 | 1 | 1 | +54.29% |
| ANDERSON TIMOTHY B | director | 200765 0.1081% | $1.76 | 1 | 6 | +47.63% |
| GLASSELL CLAES | Executive Officer and Director | 176902 0.0953% | $1.76 | 4 | 0 | +52.37% |
| SCHULZE GAIL | director | 83420 0.0449% | $1.76 | 1 | 4 | <0.0001% |
| Lucena Ann | director | 72284 0.0389% | $1.76 | 1 | 0 | |
| DAWSON WILLIAM J | Chief Financial Officer | 53195 0.0286% | $1.76 | 2 | 0 | +50.47% |
| MOORE TIMOTHY L. | director | 7911 0.0043% | $1.76 | 2 | 0 | +33.47% |
| COZADD BRUCE C | director | 5455 0.0029% | $1.76 | 0 | 3 |
Institutional Investor Ownership
| ARK Investment Management LLC | $40.72M | 11.65 | 21.55M | +3.02% | +$1.19M | 0.14 | |
| Baker Bros Advisors LP | $36.81M | 10.54 | 19.48M | 0% | +$0 | 0.26 | |
| BlackRock | $25.77M | 7.38 | 13.64M | -0.67% | -$172,825.38 | <0.01 | |
| The Vanguard Group | $18.87M | 5.4 | 9.98M | +1.15% | +$214,121.88 | <0.0001 | |
| PRIMECAP Management Co | $16.22M | 4.64 | 8.58M | -0.34% | -$54,810.00 | 0.01 | |
| Sumitomo Mitsui Trust Holdings | $14.65M | 4.19 | 7.75M | +2.41% | +$345,168.81 | 0.01 | |
| Nikko Asset Management Americas Inc | $14.57M | 4.19 | 7.75M | +2.41% | +$343,342.52 | 0.11 | |
| Senvest Management Llc | $13.85M | 3.96 | 7.33M | +11.29% | +$1.41M | 0.06 | |
| Wasatch Advisors | $11.88M | 3.4 | 6.28M | -3.77% | -$464,779.37 | 0.06 | |
| Geode Capital Management | $7.87M | 2.25 | 4.16M | +3.73% | +$282,826.39 | <0.01 | |
| State Street | $6.94M | 1.99 | 3.67M | +4.46% | +$296,567.46 | <0.0001 | |
| D. E. Shaw & Co. | $6.23M | 1.78 | 3.29M | +14.88% | +$806,421.39 | 0.01 | |
| Silvercrest Asset Management Group Inc | $5.1M | 1.46 | 2.7M | +4.44% | +$216,646.90 | 0.04 | |
| IEQ Capital | $4.05M | 1.16 | 2.14M | New | +$4.05M | 0.06 | |
| Bank of America | $3.98M | 1.14 | 2.11M | +2,576.91% | +$3.83M | <0.0001 | |
| Voya Investment Management LLC | $3.82M | 1.09 | 2.02M | -22.05% | -$1.08M | <0.01 | |
| Morgan Stanley | $3.8M | 1.09 | 2.01M | +43.71% | +$1.16M | <0.0001 | |
| Charles Schwab | $3.23M | 0.92 | 1.71M | +3.01% | +$94,190.04 | <0.01 | |
| Northern Trust | $3.06M | 0.88 | 1.62M | -1.04% | -$32,086.53 | <0.0001 | |
| Silverarc Capital Management Llc | $2.77M | 0.79 | 1.47M | -2.27% | -$64,462.23 | 0.03 | |
| Barclays | $2.69M | 0.77 | 1.42M | -10.54% | -$316,456.36 | <0.01 | |
| Sepio Capital | $2.55M | 0.73 | 1.35M | +813.56% | +$2.27M | 0.26 | |
| Citadel Advisors LLC | $2.25M | 0.64 | 1.19M | -53.3% | -$2.56M | <0.01 | |
| Assenagon Asset Management S.A. | $2.09M | 0.6 | 1.11M | +105.28% | +$1.07M | 0.01 | |
| Goldman Sachs | $1.7M | 0.49 | 899,059 | +27.71% | +$368,693.75 | <0.0001 | |
| Gsa Capital Partners Llp | $1.62M | 0.46 | 856,511 | -14.68% | -$278,504.12 | 0.13 | |
| Millennium Management LLC | $1.23M | 0.35 | 648,670 | -75.98% | -$3.88M | <0.01 | |
| BNY Mellon | $1.05M | 0.3 | 557,373 | -10.14% | -$118,860.21 | <0.0001 | |
| Nuveen | $840,368.00 | 0.24 | 444,639 | 0% | +$0 | <0.0001 | |
| Fidelity Investments | $784,647.00 | 0.23 | 415,157 | +9.06% | +$65,191.79 | <0.0001 | |
| UBS | $659,625.00 | 0.19 | 349,008 | -14.14% | -$108,629.62 | <0.0001 | |
| Raymond James Associates | $596,333.00 | 0.17 | 315,520 | -12.9% | -$88,357.53 | <0.0001 | |
| Hood River Capital Management LLC | $566,422.00 | 0.16 | 299,694 | New | +$566,422.00 | 0.01 | |
| Bouvel Investment Partners LLC | $510,015.00 | 0.15 | 269,849 | +4.75% | +$23,103.38 | 0.24 | |
| Renaissance Technologies | $509,000.00 | 0.15 | 269,300 | -1.75% | -$9,072.41 | <0.01 | |
| Engineers Gate Manager Lp | $499,089.00 | 0.14 | 264,068 | -1.71% | -$8,682.67 | 0.01 | |
| Formula Growth Ltd | $457,928.00 | 0.13 | 242,290 | 0% | +$0 | 0.15 | |
| RhumbLine Advisers | $456,809.00 | 0.13 | 241,705 | +3.36% | +$14,839.84 | <0.0001 | |
| Stifel | $446,382.00 | 0.13 | 236,177 | +2.03% | +$8,892.60 | <0.01 | |
| Levin Easterly Partners Llc | $405,001.00 | 0.12 | 214,286 | New | +$405,001.00 | 0.03 | |
| Marshall Wace | $382,872.00 | 0.11 | 202,578 | New | +$382,872.00 | <0.0001 | |
| Man Group Plc | $377,104.00 | 0.11 | 199,526 | -41.82% | -$271,016.45 | <0.01 | |
| T. Rowe Price | $365,000.00 | 0.1 | 192,873 | +4.88% | +$16,997.87 | <0.0001 | |
| AllianceBernstein | $331,701.00 | 0.1 | 175,503 | -13.15% | -$50,219.24 | <0.0001 | |
| Ameriprise Financial | $331,225.00 | 0.1 | 175,251 | +474.71% | +$273,591.23 | <0.0001 | |
| Jane Street Capital | $309,398.00 | 0.09 | 163,703 | -67.4% | -$639,621.86 | <0.0001 | |
| Walleye Capital | $290,716.00 | 0.08 | 153,818 | +551.85% | +$246,117.67 | <0.01 | |
| HSBC | $256,224.00 | 0.07 | 135,568 | +41.14% | +$74,685.38 | <0.0001 | |
| Stephens Inc. | $219,531.00 | 0.06 | 116,154 | -28.22% | -$86,325.73 | <0.01 | |
| Cubist Systematic Strategies | $211,946.00 | 0.06 | 112,141 | +90.5% | +$100,687.63 | <0.01 |